CA955850A - Process for preparing live virus vaccines - Google Patents

Process for preparing live virus vaccines

Info

Publication number
CA955850A
CA955850A CA110,999A CA110999A CA955850A CA 955850 A CA955850 A CA 955850A CA 110999 A CA110999 A CA 110999A CA 955850 A CA955850 A CA 955850A
Authority
CA
Canada
Prior art keywords
live virus
virus vaccines
preparing live
preparing
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA110,999A
Other languages
English (en)
Other versions
CA110999S (en
Inventor
Koichi Ono
Takeo Konobe
Tetsuo Onoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Application granted granted Critical
Publication of CA955850A publication Critical patent/CA955850A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA110,999A 1970-04-22 1971-04-21 Process for preparing live virus vaccines Expired CA955850A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3527470A JPS5013333B1 (en:Method) 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
CA955850A true CA955850A (en) 1974-10-08

Family

ID=12437194

Family Applications (1)

Application Number Title Priority Date Filing Date
CA110,999A Expired CA955850A (en) 1970-04-22 1971-04-21 Process for preparing live virus vaccines

Country Status (9)

Country Link
JP (1) JPS5013333B1 (en:Method)
BE (1) BE766093A (en:Method)
CA (1) CA955850A (en:Method)
CH (1) CH563459A5 (en:Method)
DE (1) DE2119688C3 (en:Method)
FR (1) FR2092068B1 (en:Method)
GB (1) GB1349362A (en:Method)
IT (1) IT1001467B (en:Method)
NL (2) NL173598C (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof

Also Published As

Publication number Publication date
FR2092068B1 (en:Method) 1977-04-15
DE2119688B2 (de) 1979-08-09
NL8303134A (nl) 1984-01-02
NL173598B (nl) 1983-09-16
CH563459A5 (en:Method) 1975-06-30
IT1001467B (it) 1976-04-20
DE2119688A1 (de) 1971-11-04
GB1349362A (en) 1974-04-03
FR2092068A1 (en:Method) 1972-01-21
JPS5013333B1 (en:Method) 1975-05-19
BE766093A (fr) 1971-09-16
NL7105497A (en:Method) 1971-10-26
NL173598C (nl) 1984-02-16
DE2119688C3 (de) 1980-04-24

Similar Documents

Publication Publication Date Title
CA930494A (en) Process for preparing polyolefin-substituted amines
CS191868B2 (en) Method of preparing live virus vaccine
CA983489A (en) Process for preparing 2-substituted-5-sulfamylbenzoic acids
CA955850A (en) Process for preparing live virus vaccines
IL37682A0 (en) Process for the manufacture of a live vaccine against the infectious bursitis of chickens
AU476149B2 (en) Process for preparing live virus vaccines
AU2793871A (en) Process for preparing live virus vaccines
CA974910A (en) Process for preparing l-arginase
AU3252271A (en) Vaccine preparation
YU248971A (en) Process for preparing 1-aminoalkane-1,1-diphosphic acids
IL37827A (en) Process for preparing substituted cobamides
CA935816A (en) Process for preparing 3-isoxazolylcarbonylureides
CA990728A (en) Process for preparing triketoimidazolidines
AU456693B2 (en) Improvements; in virus vaccines
CA932234A (en) Process for preparing barium-containing dispersion
ZA712711B (en) Process for the preparation of alive varicella virus useful as an antigen in a vaccine
CA836030A (en) Process for preparing methyl hexadienoates
AU463823B2 (en) Method forthe production ofa killed or live virus vaccine
CA925088A (en) Process for preparing 8-amino-theophylline derivatives
CA793806A (en) Process for preparing interfering virus
CA837609A (en) Process for preparing 14-hydroxydihydronormorphinones
CA978532A (en) Process for preparing 4-hydroxy-6-arylpyrimidines
CA978531A (en) Process for preparing 4-hydroxy-6-arylpyrimidines
CA837667A (en) Process for preparing meta-alkylphenols
CA846848A (en) Process for preparing dialkyl anilinomethylenemalonates